التفاصيل البيبلوغرافية
| العنوان: |
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma ; A Phase 2 Nonrandomized Controlled Trial |
| المؤلفون: |
Kazandjian, Dickran, Hill, Elizabeth, Dew, Alexander, Morrison, Candis, Roswarski, Joseph, Korde, Neha, Emanuel, Michael, Petrosyan, Ani, Bhutani, Manisha, Calvo, Katherine R., Dulau-Florea, Alina, Kwok, Mary, Lee, Min-Jung, Lee, Sunmin, Lindenberg, Liza, Mailankody, Sham, Manasanch, Elisabet, Maric, Irina, Mena, Esther, Patel, Nisha, Tageja, Nishant, Trepel, Jane B., Turkbey, Baris, Wang, Hao-Wei, Wang, Weixin, Yuan, Constance, Zhang, Yong, Braylan, Raul, Choyke, Peter, Stetler-Stevenson, Maryalice, Steinberg, Seth M., Figg, William D., Roschewski, Mark, Landgren, Ola |
| المصدر: |
JAMA Oncology ; volume 7, issue 11, page 1678 ; ISSN 2374-2437 |
| بيانات النشر: |
American Medical Association (AMA) |
| سنة النشر: |
2021 |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1001/jamaoncol.2021.3971 |
| الاتاحة: |
http://dx.doi.org/10.1001/jamaoncol.2021.3971
https://jamanetwork.com/journals/jamaoncology/articlepdf/2783765/jamaoncology_kazandjian_2021_oi_210060_1636656347.71522.pdf |
| رقم الانضمام: |
edsbas.92111886 |
| قاعدة البيانات: |
BASE |